NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
Show detailsBibliographic details: Wen F, Zhao Z, Liu C, Yin Q, Weng J, Wang Y, Ma Y. A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility. Tumor Biology 2014; 35(4): 2959-2965. [PubMed: 24234258]
Abstract
Published data regarding the association between the excision repair cross-complimentary group 2 (ERCC2) Asp312Asn polymorphisms and esophageal cancer susceptibility remained controversial. This meta-analysis of literatures was performed to assess the strength of association between the ERCC2 and esophageal cancer susceptibility using random effects model. We systematically searched PubMed, Embase and Web of Science with a time limit of September 15, 2013. Summary odds ratios (ORs) with 95 % confidence intervals (CIs) were used to assess the strength of association between the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility using random effects model. A total of seven case-control studies including 1,831 cases and 2,728 controls were included for analysis. Overall, a significant association was found between ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility for GA vs. GG (OR = 1.20, 95 % CI = 1.03-1.40) and for the dominant model GA/AA vs. GG (OR = 1.18, 95 % CI = 1.03-1.35). However, the ERCC2 Asp312Asn polymorphism was a protective factor for AA vs. GA/GG (OR = 0.63, 95 % CI = 1.15-2.65) in esophageal squamous cell carcinoma. Our meta-analysis suggested that the ERCC2 Asp312Asn polymorphism might be associated with increased risk of esophageal adenocarcinoma and a protective factor for esophageal squamous cell carcinoma.
- Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.[Genet Test Mol Biomarkers. 2014]Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.Tan X, Wang Y, Shi L, Xian L, Guo J, Liang G, Chen M. Genet Test Mol Biomarkers. 2014 Jan; 18(1):50-6. Epub 2013 Oct 1.
- Review Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.[World J Gastroenterol. 2014]Review Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.Yang R, Zhang C, Malik A, Shen ZD, Hu J, Wu YH. World J Gastroenterol. 2014 Nov 28; 20(44):16765-73.
- Review Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.[Oncotarget. 2017]Review Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.Xiao F, Pu J, Wen Q, Huang Q, Zhang Q, Huang B, Huang S, Lan A, Zhang Y, Li J, et al. Oncotarget. 2017 Jul 18; 8(29):48488-48506.
- Review Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.[Gene. 2013]Review Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.Ma Q, Qi C, Tie C, Guo Z. Gene. 2013 Nov 10; 530(2):309-14. Epub 2013 Aug 23.
- Review Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.[Asian Pac J Cancer Prev. 2014]Review Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.Zhou JY, He LW, Liu J, Yu HL, Wei M, Ma WL, Shi R. Asian Pac J Cancer Prev. 2014; 15(21):9347-53.
- A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susc...A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
Your browsing activity is empty.
Activity recording is turned off.
See more...